Literature DB >> 6627167

Bendectin: the wrong way to regulate drug availability.

J S Leeder, S P Spielberg, S M MacLeod.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6627167      PMCID: PMC1875483     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  17 in total

1.  Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score.

Authors:  S Shapiro; O P Heinonen; V Siskind; D W Kaufman; R R Monson; D Slone
Journal:  Am J Obstet Gynecol       Date:  1977-07-01       Impact factor: 8.661

2.  Congenital deformities.

Authors:  D C Paterson
Journal:  Can Med Assoc J       Date:  1969-08-09       Impact factor: 8.262

3.  Unusual fetal malformations after antiemetics in early pregnancy.

Authors:  R Harris
Journal:  Br Med J       Date:  1978-03-18

4.  Is Bendectin a teratogen?

Authors:  J F Cordero; G P Oakley; F Greenberg; L M James
Journal:  JAMA       Date:  1981-06-12       Impact factor: 56.272

5.  Debendox and congenital malformations in Northern Ireland.

Authors:  D W Harron; K Griffiths; R G Shanks
Journal:  Br Med J       Date:  1980-11-22

6.  How safe is Bendectin?

Authors:  G B Kolata
Journal:  Science       Date:  1980-10-31       Impact factor: 47.728

7.  An evaluation of the teratogenicity of certain antinauseant drugs.

Authors:  L Milkovich; B J van den Berg
Journal:  Am J Obstet Gynecol       Date:  1976-05-15       Impact factor: 8.661

8.  Teratogenicity testing in humans: a method demonstrating safety of bendectin.

Authors:  R W Smithells; S Sheppard
Journal:  Teratology       Date:  1978-02

9.  Exogenous hormones and other drug exposures of children with congenital heart disease.

Authors:  K J Rothman; D C Fyler; A Goldblatt; M B Kreidberg
Journal:  Am J Epidemiol       Date:  1979-04       Impact factor: 4.897

10.  Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects.

Authors:  A A Mitchell; L Rosenberg; S Shapiro; D Slone
Journal:  JAMA       Date:  1981-06-12       Impact factor: 56.272

View more
  3 in total

1.  Monitoring and avoiding drug and chemical teratogenicity.

Authors:  G Koren; S M MacLeod
Journal:  CMAJ       Date:  1986-11-15       Impact factor: 8.262

2.  International misregulation of drugs?

Authors:  J M Davies; L Strunin; W D Writer
Journal:  Can Med Assoc J       Date:  1984-05-01       Impact factor: 8.262

3.  Early pregnancy exposure to antihistamines and risk of congenital heart defects: results of two case-control studies.

Authors:  Huberdina P M Smedts; Linda de Jonge; Sarah J G Bandola; Marlies E Baardman; Marian K Bakker; Bruno H C Stricker; Régine P M Steegers-Theunissen
Journal:  Eur J Epidemiol       Date:  2014-06-20       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.